vs
Side-by-side financial comparison of Mind Medicine (MindMed) Inc. (DFTX) and OLB GROUP, INC. (OLB). Click either name above to swap in a different company.
OLB GROUP, INC. is the larger business by last-quarter revenue ($1.8M vs $906.0K, roughly 2.0× Mind Medicine (MindMed) Inc.). OLB GROUP, INC. runs the higher net margin — -83.7% vs -2634.0%, a 2550.3% gap on every dollar of revenue. On growth, Mind Medicine (MindMed) Inc. posted the faster year-over-year revenue change (-16.1% vs -35.2%).
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
OLB Group, Inc. is a global financial technology provider offering omnichannel payment processing solutions, e-commerce enablement tools, and digital banking services for small and medium-sized enterprises across North America, Europe, and key Asia-Pacific markets. Its core segments include merchant services, crypto payment integration, and cloud-based business management platforms.
DFTX vs OLB — Head-to-Head
Income Statement — Q4 FY2023 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $906.0K | $1.8M |
| Net Profit | $-23.9M | $-1.5M |
| Gross Margin | — | — |
| Operating Margin | -2450.8% | -83.7% |
| Net Margin | -2634.0% | -83.7% |
| Revenue YoY | -16.1% | -35.2% |
| Net Profit YoY | -386.7% | 67.5% |
| EPS (diluted) | $-0.58 | $-0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.8M | ||
| Q3 25 | — | $2.3M | ||
| Q2 25 | — | $2.3M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $2.7M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $3.5M | ||
| Q1 24 | — | $3.5M |
| Q4 25 | — | $-1.5M | ||
| Q3 25 | — | $-1.2M | ||
| Q2 25 | — | $-2.1M | ||
| Q1 25 | — | $-1.1M | ||
| Q4 24 | — | $-4.6M | ||
| Q3 24 | — | $-1.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | — | $-2.4M |
| Q4 25 | — | -83.7% | ||
| Q3 25 | — | -49.1% | ||
| Q2 25 | — | -74.8% | ||
| Q1 25 | — | -36.6% | ||
| Q4 24 | — | -166.0% | ||
| Q3 24 | — | -52.9% | ||
| Q2 24 | — | -74.3% | ||
| Q1 24 | — | -82.6% |
| Q4 25 | — | -83.7% | ||
| Q3 25 | — | -50.8% | ||
| Q2 25 | — | -93.7% | ||
| Q1 25 | — | -46.9% | ||
| Q4 24 | — | -167.1% | ||
| Q3 24 | — | -52.9% | ||
| Q2 24 | — | -75.2% | ||
| Q1 24 | — | -67.8% |
| Q4 25 | — | $-0.48 | ||
| Q3 25 | — | $-0.13 | ||
| Q2 25 | — | $-0.66 | ||
| Q1 25 | — | $-0.47 | ||
| Q4 24 | — | $-3.55 | ||
| Q3 24 | — | $-0.92 | ||
| Q2 24 | — | $-1.49 | ||
| Q1 24 | — | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $99.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $78.1M | $4.6M |
| Total Assets | $124.5M | $12.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $29.3K | ||
| Q4 24 | — | $27.4K | ||
| Q3 24 | — | $41.3K | ||
| Q2 24 | — | $53.3K | ||
| Q1 24 | — | $3.3K |
| Q4 25 | — | $4.6M | ||
| Q3 25 | — | $5.3M | ||
| Q2 25 | — | $6.4M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $6.7M | ||
| Q2 24 | — | $8.3M | ||
| Q1 24 | — | $11.0M |
| Q4 25 | — | $12.3M | ||
| Q3 25 | — | $12.2M | ||
| Q2 25 | — | $12.4M | ||
| Q1 25 | — | $12.5M | ||
| Q4 24 | — | $12.7M | ||
| Q3 24 | — | $15.9M | ||
| Q2 24 | — | $16.6M | ||
| Q1 24 | — | $18.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-20.6M | $-1.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.3M | ||
| Q3 25 | — | $-115.5K | ||
| Q2 25 | — | $-1.0M | ||
| Q1 25 | — | $-155.8K | ||
| Q4 24 | — | $-2.6M | ||
| Q3 24 | — | $-376.7K | ||
| Q2 24 | — | $-785.5K | ||
| Q1 24 | — | $-424.7K |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DFTX
Segment breakdown not available.
OLB
| Transaction And Processing Fees | $1.7M | 94% |
| Other | $99.2K | 6% |
